By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



35 Ehad Ha-Am Street

  Tel-Aviv  65202   Israel
Phone: n/a Fax: n/a


Company News
Alcobra (ADHD) Release: Company Stock Decimated As ADHD Drug Flunks Phase III Test 1/17/2017 5:34:55 AM
Alcobra (ADHD) Provides Update On Recent FDA Meeting And Path Forward For MDX Clinical Development Program 1/9/2017 7:17:50 AM
Alcobra (ADHD) Updates On Recent FDA Meeting 12/14/2016 6:56:41 AM
Alcobra (ADHD) Announces Third Quarter 2016 Financial Results And Provides Corporate Update 11/15/2016 9:14:48 AM
Alcobra (ADHD) To Release Third Quarter Financial Results And Host Corporate Update Conference Call & Webcast On November 15 11/1/2016 10:51:51 AM
Update from Alcobra (ADHD) On Recent FDA Communications 10/7/2016 7:14:58 AM
FDA Slaps Clinical Hold on Alcobra (ADHD)'s Late Stage ADHD Study 9/29/2016 5:32:29 AM
Alcobra (ADHD) Announces Second Quarter 2016 Financial Results And Provides Corporate Update 8/30/2016 7:56:21 AM
Alcobra (ADHD) Granted European Orphan Drug Designation For Metadoxine In Fragile X Syndrome 7/19/2016 8:21:53 AM
Alcobra (ADHD) To Participate In Upcoming Investment Conferences 6/1/2016 8:24:09 AM